肿瘤模型Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
期刊:Cancer letters发表年份:2017作者:Bo Yuan; Na Ye; Shan-Shan Song; Yu-Ting Wang; Zilan Song; Hua-Dong Chen; Chuan-Huizi Chen; Xia-Juan Huan; Ying-Qing Wang; Yi Su; Yan-Yan Shen; Yi-Ming Sun; Xin-Ying Yang; Yi Chen; Shi-Yan Guo; Yong Gan; Zhi-Wei Gao; Xiao-Yan Chen; Jian Ding; Jin-Xue
